PRIMARY OPEN ANGLE GLAUCOMA (POAG)
Clinical trials for PRIMARY OPEN ANGLE GLAUCOMA (POAG) explained in plain language.
Never miss a new study
Get alerted when new PRIMARY OPEN ANGLE GLAUCOMA (POAG) trials appear
Sign up with your email to follow new studies for PRIMARY OPEN ANGLE GLAUCOMA (POAG), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a Mitochondria-Boosting drug help save sight in glaucoma?
Disease control CompletedThis completed Phase 4 trial tested the drug Mexidol in 80 people with advanced primary open-angle glaucoma. The goal was to see if the drug could improve the function of mitochondria in cells and protect the optic nerve. Participants were randomly assigned to receive Mexidol or …
Matched conditions: PRIMARY OPEN ANGLE GLAUCOMA (POAG)
Phase: PHASE4 • Sponsor: Pharmasoft • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Can mexidol help glaucoma patients see better?
Disease control CompletedThis study tested different doses of the drug Mexidol in 102 adults with moderate to advanced open-angle glaucoma. The goal was to see if the drug could improve vision compared to a placebo. Participants took the drug or placebo in a sequence over several months, and their vision…
Matched conditions: PRIMARY OPEN ANGLE GLAUCOMA (POAG)
Phase: PHASE2 • Sponsor: Pharmasoft • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC